top of page

 Welcoming Stephen Spellicy to the board

Mountain View, Calif., Oct 27, 2023 -- GTcardio announced Stephen Spellicy is joining GTCardio as a member of the board of advisors. With a broad executive background spanning both IoT, AI, and Information Management, Stephen brings a multifaceted perspective to GTcardio’s mission.

Stephen is a leader in cloud computing and virtualization applied to healthcare and IoT. With expertise in product management, marketing, go-to-market, and business development, he has been instrumental in steering substantial business growth, from SMBs to Enterprise. 

Taking on the role of Vice President at VMware, Spellicy focused on strategies that augment market presence in large cloud environments for the telecom sector. Earlier, during his tenure at Thales, as SVP of Product Management, he managed and marketed an AI/ML-driven initiative targeting IoT, transportation, and aerospace verticals. His professional arc also includes valuable experiences at establishments like Hewlett Packard Enterprise, Virtensys (later acquired by Micron), EMC, and a range of other tech entities, where he assumed varied roles from technical marketing to pivotal leadership.


"Welcome, Stephen Spellicy; your expertise as an advisor adds exceptional talent to GTcardio’s stellar team," said Silvia Veronese, CEO of GTcardio. "We look forward to more innovation and success together, developing new opportunities in the medical markets for GTcardio. Your expansive roles, ranging from product management, marketing to business development, provide a comprehensive lens that will be instrumental in charting our growth trajectory.” 

“I am honored to have the opportunity to work with technology visionary, inventor, CEO Silvia Veronese” says Stephen Spellicy. “I believe GTcardio is uniquely positioned to capitalize on the changing healthcare environment. As the industry evolves through innovation, consolidation, and technology migrations, GTcardio leads to provide a cost-effective and timely solution for continuous cardiovascular care and to help in any capacity, utilizing my skills as well as helping them find new solutions to problems that will be revealed along the way and that they will be able to solve. ”


About GTcardio Inc. 

GTcardio is a biotechnology company that specializes in the development of non-invasive continuous cardiovascular monitoring. 

The company's flagship product is a patented platform that allows for real-time monitoring of hemodynamic indicators including blood pressure and cardiac output. This technology is designed to improve patient outcomes and reduce healthcare costs by providing accurate and timely information to clinicians. 

GTcardio is headquartered in Silicon Valley, CA, and has offices in Israel, China, Japan, and India.

For more information, visit 

Please contact

bottom of page